Revolution Medicines, Inc.

RVMD stock score: 45/100

$196.55 · +7.91% · Scored Oct 20, 2026

Technical
66
Fundamental
24
News
56

The reading

Revolution Medicines (RVMD) scores 45 out of 100, which reads weak, higher than 48% of Healthcare stocks and 29% of the 4,166 US stocks we score.

The composite is technicals and fundamentals weighted equally: technicals read 66, fundamentals 24.

Among the fundamentals, Quick Ratio at 100 and Current Ratio at 100 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 48 and contrarian oscillators 63.

News sentiment is neutral at 56; it is shown, not counted in the composite.

Since Jul 25, 2026 the composite has ranged from 41 to 69, and it is down 23 points over the period.

What’s driving the score

The strongest and weakest of the scorers that count toward RVMD’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

24

Pulling it up

  • Quick Ratio100

    Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Current Ratio100

    Current ratio measures ability to pay short-term liabilities with current assets.

  • Fund Ownership100

    Fund ownership tracks institutional investor holdings and changes.

Holding it back

  • Earnings Profitability (Quarterly)0

    Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.

  • Earnings Quality (Quarterly)0

    Quarterly earnings quality assesses the sustainability and reliability of reported profits.

  • Earnings Quality (Annual)0

    Earnings Quality (Annual) assesses absolute profitability independent of growth, measuring whether the company is profitable, its earnings yield (earnings/market cap), profit margins, and consistency.

33 weighted scorers; 8 had no data today and are left out rather than counted as zero.

Technical · daily

52

Pulling it up

  • EMA 50 Cross Up100

    EMA 50 Cross Up detects when price crosses above the 50-period EMA.

  • SMA 100 Cross Up100

    SMA 100 Cross Up identifies when shorter averages cross above the 100-period SMA.

  • 52-Week Change100

    The price change over the last 52 weeks.

Holding it back

  • Parabolic SAR (PSAR)0

    Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.

  • Ichimoku Cloud7

    Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

  • TRIX7

    TRIX is a momentum oscillator that filters out short-term noise by triple-smoothing price data.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
56

Technical score by timeframe

ChartScoreWeight
Hourly611
Daily523
Weekly652
Monthly742
Quarterly812

Composite score, last 90 days

05010045Jul 25, 2026Oct 20, 2026Jul 25, 2026: 68Jul 26, 2026: 68Jul 27, 2026: 68Jul 28, 2026: 66Jul 29, 2026: 67Jul 30, 2026: 69Jul 31, 2026: 54Aug 2, 2026: 51Aug 3, 2026: 51Aug 4, 2026: 53Aug 5, 2026: 52Aug 6, 2026: 52Aug 7, 2026: 53Aug 8, 2026: 51Aug 9, 2026: 52Aug 10, 2026: 53Aug 11, 2026: 52Aug 12, 2026: 52Aug 13, 2026: 51Aug 14, 2026: 51Aug 15, 2026: 52Aug 16, 2026: 52Aug 17, 2026: 53Aug 18, 2026: 53Aug 19, 2026: 53Aug 20, 2026: 52Aug 22, 2026: 47Aug 23, 2026: 47Aug 24, 2026: 47Aug 25, 2026: 48Aug 26, 2026: 48Aug 27, 2026: 49Aug 28, 2026: 47Aug 29, 2026: 47Aug 30, 2026: 47Aug 31, 2026: 46Sep 1, 2026: 48Sep 2, 2026: 48Sep 3, 2026: 47Sep 4, 2026: 46Sep 5, 2026: 47Sep 6, 2026: 47Sep 7, 2026: 47Sep 8, 2026: 47Sep 9, 2026: 47Sep 10, 2026: 44Sep 11, 2026: 45Sep 12, 2026: 45Sep 13, 2026: 45Sep 14, 2026: 46Sep 15, 2026: 45Sep 16, 2026: 43Sep 17, 2026: 44Sep 18, 2026: 43Sep 19, 2026: 43Sep 20, 2026: 43Sep 21, 2026: 44Sep 22, 2026: 44Sep 23, 2026: 46Sep 24, 2026: 47Sep 25, 2026: 48Sep 26, 2026: 47Sep 27, 2026: 47Sep 28, 2026: 46Sep 29, 2026: 47Sep 30, 2026: 47Oct 1, 2026: 47Oct 2, 2026: 46Oct 3, 2026: 47Oct 4, 2026: 47Oct 5, 2026: 47Oct 6, 2026: 45Oct 7, 2026: 45Oct 8, 2026: 43Oct 9, 2026: 43Oct 10, 2026: 43Oct 11, 2026: 43Oct 12, 2026: 44Oct 13, 2026: 43Oct 14, 2026: 44Oct 15, 2026: 43Oct 16, 2026: 41Oct 17, 2026: 41Oct 18, 2026: 41Oct 19, 2026: 42Oct 20, 2026: 45
Show the daily numbers
DateComposite
Oct 20, 202645
Oct 19, 202642
Oct 18, 202641
Oct 17, 202641
Oct 16, 202641
Oct 15, 202643
Oct 14, 202644
Oct 13, 202643
Oct 12, 202644
Oct 11, 202643
Oct 10, 202643
Oct 9, 202643
Oct 8, 202643
Oct 7, 202645
Oct 6, 202645
Oct 5, 202647
Oct 4, 202647
Oct 3, 202647
Oct 2, 202646
Oct 1, 202647
Sep 30, 202647
Sep 29, 202647
Sep 28, 202646
Sep 27, 202647
Sep 26, 202647
Sep 25, 202648
Sep 24, 202647
Sep 23, 202646
Sep 22, 202644
Sep 21, 202644
Sep 20, 202643
Sep 19, 202643
Sep 18, 202643
Sep 17, 202644
Sep 16, 202643
Sep 15, 202645
Sep 14, 202646
Sep 13, 202645
Sep 12, 202645
Sep 11, 202645
Sep 10, 202644
Sep 9, 202647
Sep 8, 202647
Sep 7, 202647
Sep 6, 202647
Sep 5, 202647
Sep 4, 202646
Sep 3, 202647
Sep 2, 202648
Sep 1, 202648
Aug 31, 202646
Aug 30, 202647
Aug 29, 202647
Aug 28, 202647
Aug 27, 202649
Aug 26, 202648
Aug 25, 202648
Aug 24, 202647
Aug 23, 202647
Aug 22, 202647
Aug 20, 202652
Aug 19, 202653
Aug 18, 202653
Aug 17, 202653
Aug 16, 202652
Aug 15, 202652
Aug 14, 202651
Aug 13, 202651
Aug 12, 202652
Aug 11, 202652
Aug 10, 202653
Aug 9, 202652
Aug 8, 202651
Aug 7, 202653
Aug 6, 202652
Aug 5, 202652
Aug 4, 202653
Aug 3, 202651
Aug 2, 202651
Jul 31, 202654
Jul 30, 202669
Jul 29, 202667
Jul 28, 202666
Jul 27, 202668
Jul 26, 202668
Jul 25, 202668

Key facts

Market cap
$42.1B
Sector
Healthcare
Industry
Biotechnology
Beta
1.40
Risk grade (1–10)
7
Next earnings
Nov 4, 2026

Biotechnology peers

CompanyMarket capScore
ARGX argenx SE$54.7B64
ONC BeOne Medicines AG$43.7B66
RPRX Royalty Pharma$36.0B60
ALNY Alnylam Pharmaceuticals$30.9B56
ROIV Roivant Sciences$25.2B45
GMAB Genmab A/S$24.0B68

Questions

What is RVMD's stock score today?

RVMD scores 45/100 (Weak) as of Oct 20, 2026: technical 66, fundamental 24, and news sentiment 56, which is shown but not counted. Scores are recomputed every night.

Is RVMD a buy?

The score is not a buy or sell recommendation. A 45 says the technical and fundamental signals we measure lean weak today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the RVMD score calculated?

95 weighted scorers feed it today: 33 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.